An innovative biomimetic model of the human immune system known as MIMIC® system has been developed by scientists. This model facilitates faster, more effective vaccine development.
"Our goal is to increase the likelihood of success within the clinic- to make better drugs and vaccines and get them into the marketplace and to the patients faster," says William Warren, PhD, Head of the VaxDesign Campus, Sanofi Pasteur. "This in vitro human immune system enables us to measure vaccine efficacy earlier and more predictably."
AdvertisementThe MIMIC® platform represents a truly disruptive technology for the study of vaccines and other biologics with immunomodulatory potential, as it provides a novel in vitro model for evaluating human immune responses against candidate drugs, adjuvants, and vaccines. It has shown game-changing advantages over conventional approaches to safety and efficacy testing.
You May Also Like